HILS vs. AIMD, ASLN, PULM, BFRI, PCSA, IBIO, XBIO, VCNX, FWBI, and TENX
Should you be buying Hillstream BioPharma stock or one of its competitors? The main competitors of Hillstream BioPharma include Ainos (AIMD), ASLAN Pharmaceuticals (ASLN), Pulmatrix (PULM), Biofrontera (BFRI), Processa Pharmaceuticals (PCSA), iBio (IBIO), Xenetic Biosciences (XBIO), Vaccinex (VCNX), First Wave BioPharma (FWBI), and Tenax Therapeutics (TENX). These companies are all part of the "pharmaceutical preparations" industry.
Hillstream BioPharma (NASDAQ:HILS) and Ainos (NASDAQ:AIMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.
Hillstream BioPharma has higher earnings, but lower revenue than Ainos.
Hillstream BioPharma has a beta of 3.08, suggesting that its stock price is 208% more volatile than the S&P 500. Comparatively, Ainos has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500.
Hillstream BioPharma received 1 more outperform votes than Ainos when rated by MarketBeat users.
Hillstream BioPharma has a net margin of 0.00% compared to Ainos' net margin of -15,348.14%. Ainos' return on equity of -55.38% beat Hillstream BioPharma's return on equity.
13.4% of Hillstream BioPharma shares are owned by institutional investors. 30.2% of Hillstream BioPharma shares are owned by insiders. Comparatively, 4.6% of Ainos shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, Ainos had 3 more articles in the media than Hillstream BioPharma. MarketBeat recorded 3 mentions for Ainos and 0 mentions for Hillstream BioPharma. Hillstream BioPharma's average media sentiment score of 0.00 beat Ainos' score of -0.22 indicating that Hillstream BioPharma is being referred to more favorably in the media.
Summary
Hillstream BioPharma beats Ainos on 7 of the 11 factors compared between the two stocks.
Get Hillstream BioPharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for HILS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HILS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Hillstream BioPharma Competitors List
Related Companies and Tools
